A longitudinal trial for the study of micrometastatic disease in breast cancer has been underway in our institution since 1996.
A longitudinal trial for the study of micrometastatic disease in breast cancer is ongoing in our Department since 1997.
Detailed legend: Each participating hospital selected 3 clinical trials, for which the study identifier, the disease under investigation, as well as the size of the parent population and the number of eligibility criteria are given in this table.
The materials also instruct participants in how to obtain their selected nicotine products for the trial from the study website.
This process resulted in a set of 55 trials for the current study.
There are no contractual agreements in place that limit free access to the clinical trial data for the study investigators or any other future collaborators.
It was about the melanoma trial for elesclomol, the study everyone had given up on.
In the Malmö trial, for instance, the study group was 45 69 years of age at randomization.
The authors thank the participants without whom this study would not have been possible, the Pennington Clinical Trials for the conduct of the study and Ms. Yolanda Hill for coordinating the study.
